BlackRock’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3M | Buy |
3,050,196
+1,808,161
| +146% | +$20.3M | ﹤0.01% | 2658 |
|
|
2025
Q1 | $7.08M | Sell |
1,242,035
-46,563
| -4% | -$265K | ﹤0.01% | 3448 |
|
|
2024
Q4 | $12.7M | Buy |
1,288,598
+202,211
| +19% | +$1.99M | ﹤0.01% | 3257 |
|
|
2024
Q3 | $8.85M | Buy |
1,086,387
+36,116
| +3% | +$294K | ﹤0.01% | 3424 |
|
|
2024
Q2 | $14M | Sell |
1,050,271
-771,281
| -42% | -$10.3M | ﹤0.01% | 3140 |
|
|
2024
Q1 | $84.5M | Buy |
1,821,552
+1,680
| +0.1% | +$78K | ﹤0.01% | 2120 |
|
|
2023
Q4 | $123M | Buy |
1,819,872
+2,390
| +0.1% | +$162K | ﹤0.01% | 1935 |
|
|
2023
Q3 | $132M | Buy |
1,817,482
+112,411
| +7% | +$8.14M | ﹤0.01% | 1813 |
|
|
2023
Q2 | $127M | Buy |
1,705,071
+438,469
| +35% | +$32.6M | ﹤0.01% | 1869 |
|
|
2023
Q1 | $67.4M | Buy |
1,266,602
+90,203
| +8% | +$4.8M | ﹤0.01% | 2238 |
|
|
2022
Q4 | $79.5M | Buy |
1,176,399
+399,079
| +51% | +$27M | ﹤0.01% | 2145 |
|
|
2022
Q3 | $97M | Sell |
777,320
-31,512
| -4% | -$3.93M | ﹤0.01% | 1969 |
|
|
2022
Q2 | $77M | Buy |
808,832
+410,000
| +103% | +$39M | ﹤0.01% | 2177 |
|
|
2022
Q1 | $64.3M | Sell |
398,832
-10,071
| -2% | -$1.62M | ﹤0.01% | 2398 |
|
|
2021
Q4 | $136M | Buy |
+408,903
| New | +$136M | ﹤0.01% | 1991 |
|